[go: up one dir, main page]

CA2661099C - Compositions pharmaceutiques comprenant de la cefquinome - Google Patents

Compositions pharmaceutiques comprenant de la cefquinome Download PDF

Info

Publication number
CA2661099C
CA2661099C CA2661099A CA2661099A CA2661099C CA 2661099 C CA2661099 C CA 2661099C CA 2661099 A CA2661099 A CA 2661099A CA 2661099 A CA2661099 A CA 2661099A CA 2661099 C CA2661099 C CA 2661099C
Authority
CA
Canada
Prior art keywords
cefquinome
composition according
cetostearyl ether
composition
macrogol cetostearyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2661099A
Other languages
English (en)
Other versions
CA2661099A1 (fr
Inventor
Cecile Rialland-Siebert
Carlos De Sa
Peter Gerardus Franciscus Cox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of CA2661099A1 publication Critical patent/CA2661099A1/fr
Application granted granted Critical
Publication of CA2661099C publication Critical patent/CA2661099C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA2661099A 2006-08-30 2007-08-28 Compositions pharmaceutiques comprenant de la cefquinome Expired - Fee Related CA2661099C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US84138706P 2006-08-30 2006-08-30
EP06119765.3 2006-08-30
US60/841,387 2006-08-30
EP06119765 2006-08-30
PCT/EP2007/058933 WO2008025773A1 (fr) 2006-08-30 2007-08-28 Compositions pharmaceutiques comprenant de la cefquinome

Publications (2)

Publication Number Publication Date
CA2661099A1 CA2661099A1 (fr) 2008-03-06
CA2661099C true CA2661099C (fr) 2012-01-24

Family

ID=38515712

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2661099A Expired - Fee Related CA2661099C (fr) 2006-08-30 2007-08-28 Compositions pharmaceutiques comprenant de la cefquinome

Country Status (4)

Country Link
EP (1) EP2059231A1 (fr)
AU (1) AU2007291308A1 (fr)
CA (1) CA2661099C (fr)
WO (1) WO2008025773A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009012423A1 (de) * 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
CN113952298B (zh) * 2021-12-08 2023-02-17 江苏农牧科技职业学院 硫酸头孢喹肟纳米混悬液及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2188940T3 (es) * 1996-05-10 2003-07-01 Upjohn Co Administracion topica de premafloxacina para el tratamiento de enfermedades bacterianas sistemicas.
WO2003063877A1 (fr) * 2002-02-01 2003-08-07 Akzo Nobel N.V. Composition de cefquinome pour administration intra-mammaire chez le betail
BRPI0315513B1 (pt) * 2002-10-25 2017-11-28 Intervet International B.V. Pharmaceutical composition preparation, and use of crystalline in a vehicle with prolonged release
US6911441B2 (en) * 2002-12-16 2005-06-28 Akzo Nobel N.V. Prolonged release pharmaceutical composition
AU2003290015A1 (en) * 2002-12-16 2004-07-09 Akzo Nobel N.V. Mastitis treatment
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions

Also Published As

Publication number Publication date
CA2661099A1 (fr) 2008-03-06
WO2008025773A1 (fr) 2008-03-06
EP2059231A1 (fr) 2009-05-20
AU2007291308A1 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
US4011312A (en) Prolonged release drug form for the treatment of bovine mastitis
RU2662300C2 (ru) Способы лечения микробных инфекций, в том числе мастита
CN1326526C (zh) 延长释放的药物组合物
KR20130050394A (ko) 수의학 약물에서 멜록시캄 제형의 용도
WO2010120195A1 (fr) Compositions combinées à base de lactone macrocyclique, vaccins et procédés pour les préparer
CA2661099C (fr) Compositions pharmaceutiques comprenant de la cefquinome
RU2627429C2 (ru) Составы с контролируемым высвобождением и способы их использования
US6911441B2 (en) Prolonged release pharmaceutical composition
De Cramer Surgical uterine drainage and lavage as treatment for canine pyometra: clinical communication
KR19990087178A (ko) 병변조직 치료용 외용약제
NZ574778A (en) Pharmaceutical compositions comprising cefquinome useful for the treatment of metritis in mammalian animals
US20210106602A1 (en) Injectable antibiotic formulations and use thereof
JP5322649B2 (ja) セフキノム組成物およびその使用方法
CN109045044B (zh) 一种复方药剂及其制备方法、用途
CZ20001441A3 (cs) Farmaceutický prostředek
ZA200109364B (en) A somatotropin composition with improved syringeability.
WO2004032899A1 (fr) Formulation antibiotique pour administration intra-mammaire chez des animaux laitiers
RU2140737C1 (ru) Средство для профилактики и лечения паразитарных заболеваний животных
AU2015261543B2 (en) Controlled release compositions and their methods of use
CN104983680A (zh) 一种羊用复方驱虫药的稳定性纳米悬浮制剂及其制备方法
IL303943A (en) Methods for treating mastitis using the antimicrobial orthosomycin compound

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130828